Our health care system needs to do a better job of diagnosing and supporting people with cannabis-related diseases,” a ...

More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...